The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The ...
In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.
A “search and destroy” treatment has been found to halt tumours in some men with incurable prostate cancer. The early-stage trial investigated a form of radiotherapy on patien ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results